ArticleJSES international2025
Synovial fluid leukocytes as diagnostic marker in periprosthetic shoulder infection.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Limited data exist regarding the diagnostic accuracy of synovial fluid leukocyte count (SFLC) in diagnosing periprosthetic shoulder infection (PSI). The main objective of this study was to determine the diagnostic value of leukocyte count at a common threshold of 3 cells/nL and the optimal cut-off value. Methods: Patients who underwent shoulder arthroplasty revision surgery and aspiration with SFLC between 2012 and 2023 were retrospectively included. The International Consensus Meeting 2018 definition was used to characterize infection status for SFLC threshold and synovial fluid neutrophil percentage (SFNP). Sensitivity and specificity were presented using cross tabulation. The area under the curve was calculated, and the optimal cut-off was determined using maximized Youden Index. Results: 35 cases with an average age of 71 years (43% male) were included in our study. At a threshold of 3 cells/nL, SFLC showed a sensitivity of 70% and specificity of 83%. The corresponding positive and negative predictive values (PPV and NPV) were 89% and 59%, respectively. We found the optimal cut-off for our cohort at 4.7 cells/nL, increasing specificity to 92% while maintaining sensitivity at 70% (PPV = 94%, NPV = 61%). SFNP at a cut-off of 80% demonstrated 50% sensitivity and 91% specificity, with corresponding PPV and NPV of 92% and 48%, respectively. The optimum threshold for SFNP was 54%, which had a sensitivity of 77% and a specificity of 64%, as well as a PPV of 81%, and NPV of 58%. The area under the curve was 0.72 for SFLC and 0.74 for SFNP. Sonication detected pathogens in 63% of cases, while 57% of all cases showed positive tissue cultures and 43% positive aspirate cultures. Especially, the most frequently found microorganism, Conclusions: SFLC shows good specificity but moderate sensitivity for diagnosing PSI when using a threshold of 4.7 cells/nL. Therefore, it can serve as a confirmatory test for diagnosing PSI but not for ruling out infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.